Silverarc Capital Management »

Oric Pharmaceuticals shares owned by Silverarc Capital Management

Quarter-by-quarter ownership of Oric Pharmaceuticals (ORIC) shares owned by Silverarc Capital Management from 13F filings

Historical chart of Silverarc Capital Management investment in Oric Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Oric Pharmaceuticals held by Silverarc Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oric Pharmaceuticals by Silverarc Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $6.8M 1.1M 6.05
2023-06-30 $11M 1.5M 7.76
2023-03-31 $8.2M 1.4M 5.70
2022-12-31 $7.3M 1.2M 5.89
2022-09-30 $3.9M 1.2M 3.20
2022-06-30 $4.8M 1.1M 4.48

More positions owned by Silverarc Capital Management

ImmunoGen Long Option Calls Call Option
SPRD S&P Biotech ETF Long Option Calls Call Option (XBI)
Akero Therapeutics Long Option Calls Call Option (AKRO)
Mirati Therapeutics Long Option Calls Call Option
Morphic Holding Equities (MORF)
Merus NV Equities (MRUS)
CymaBay Therapeutics Long Option Calls Call Option
Soleno Therapeutics Equities (SLNO)
Intra-Cellular Therapies Equities (ITCI)
Poseida Therapeutics Equities (PSTX)
Krystal Biotech Equities (KRYS)
Mersana Therapeutics Long Option Calls Call Option (MRSN)
KalVista Pharmaceuticals Long Option Calls Call Option (KALV)
Biogen Idec Equities (BIIB)
Urogen Pharma Equities (URGN)

View all positions for Silverarc Capital Management

Top funds holding Oric Pharmaceuticals

Nextech Invest
Column Group
EcoR1 Capital
BlackRock
Vanguard Group
VR Adviser
Frazier Life Sciences Management
Arrowpoint Asset Management
Boxer Capital
First Turn Management
Invus Financial Advisors
Euclidean Capital
Vivo Capital
Franklin Resources
Henderson Group

View all funds holding Oric Pharmaceuticals